Variation in body fat distribution contributes to the metabolic sequelae of obesity. The genetic determinants of body fat distribution are poorly understood. The goal of this study was to gain new insights into the underlying genetics of body fat distribution by conducting sample-size-weighted fixed-effects genome-wide association meta-analyses in up to 9,594 women and 8,738 men of European, African, Hispanic and Chinese ancestry, with and without sex stratification, for six traits associated with ectopic fat (hereinafter referred to as ectopicfat traits). In total, we identified seven new loci associated with ectopic-fat traits (ATXN1, UBE2E2, EBF1, RREB1, GSDMB, GRAMD3 and ENSA; P < 5 × 10 −8 ; false discovery rate < 1%). Functional analysis of these genes showed that loss of function of either Atxn1 or Ube2e2 in primary mouse adipose progenitor cells impaired adipocyte differentiation, suggesting physiological roles for ATXN1 and UBE2E2 in adipogenesis. Future studies are necessary to further explore the mechanisms by which these genes affect adipocyte biology and how their perturbations contribute to systemic metabolic disease.
VATHU), we estimated heritability (H 2 ) in 3,312 women and men in the Framingham Heart Study (FHS) and found it to be between 29% and 31% (P < 1 × 10 −15 ). To assess the shared genetic contribution between ectopic-fat traits, we estimated the genetic correlations among 3,336 women and men in the FHS. Moderate to strong statistically significant correlations were observed between almost all ectopic-fat trait pairs (0.35 to 0.67 and −0.74 to −0.35, all P < 5 × 10 −4 ; Supplementary Table 6), suggesting shared loci between ectopic-fat traits. However, not all genes were shared between traits (P < 5 × 10 −11 for non-overlapping correlations for all pairwise comparisons). The genetic correlations across the ectopic-fat traits were also reflected in the phenotypic correlations (Supplementary Table 7) .
In this combined multiethnic, sample-size-weighted, fixed-effects meta-analysis 18, 19 of up to 18,332 participants, a total of 11 locus-trait associations (seven new and four known) from 27 genomic scans (analysis of nine traits and models in three strata-overall, women and men) attained genome-wide significance (P < 5 × 10 −8 ). Of the seven new loci, three were associated with volumetric subcutaneous (GSDMB) and visceral (GRAMD3 and RREB1) fat traits, two were associated with pericardial fat (ENSA and EBF1), one was associated with fat attenuation (ATXN1), and one was associated with relative fat distribution (VAT/SAT ratio; UBE2E2) ( Table 1 and Supplementary  Fig. 1 ; imputation quality is shown in Supplementary Table 8) . Associations were robust across ancestry-stratified sensitivity analyses ( Supplementary Figs. 2 and 3, Supplementary Table 9 ). Manhattan plots and QQ plots for each analysis showed minimal inflation of association test statistics ( Supplementary Fig. 4 ). The remaining four loci that attained genome-wide significance (LYPLAL1, LY86, FTO and TRIB2) were previously identified 12, 13 . rs2123685, which is located between the 3′ untranslated regions of ZPBP2 and GSDMB, was associated with SAT in women only (P women = 3.4 × 10 −8 ; Supplementary Table 10a ). Investigation of related ectopic traits among women showed a directionally consistent nominal association with VAT (P = 4.8 × 10 −4 ). SNPs at FTO attained genome-wide significance in association with SAT in the overall sample (P = 1.4 × 10 −9 ).
The newly identified association at RREB1 with visceral adipose tissue adjusted for BMI (VATadjBMI) (rs2842895, P = 1.1 × 10 −8 ) was observed in the overall sample and in both sexes (Supplementary Table 10b ). Examination of related ectopic traits demonstrated nominal associations with VAT and VAT/SAT ratio adjusted for BMI (adjBMI) (P = 4.8 × 10 −5 and P = 8.9 × 10 −6 , respectively). The newly identified association of rs10060123 near GRAMD3 for VATadjBMI was specific to women (P = 4.5 × 10 −8 ). This locus was nominally associated with VAT and VAT/SAT ratio adjBMI in women (Supplementary Table 10c ).
Pericardial adipose tissue (PAT) represents distinct ectopic-fat deposition around the heart. Two findings in the overall sample at the ENSA and EBF1 loci (P = 2.8 × 10 −9 and 1.0 × 10 −9 , respectively; Table 1 ) have not been previously associated with ectopic fat, general adiposity or body fat distribution. Associations at ENSA and EBF1 did not seem to be sex specific (Supplementary Table 10d ,e). Further investigation of the ENSA and EBF1 loci showed no associations with SAT, VAT or the VAT/SAT ratio, underscoring their specificity to PAT. TRIB2 was associated with PAT in this and our prior meta-analysis 13 (P < 5 × 10 −8 ).
Cellular characteristics of fat quality-such as lipid content, vascularity, and adipocyte size and number-may be important factors l e t t e r s influencing metabolic risk 7, 10 , but direct assessment is invasive. CT attenuation of fat is correlated with fat-quality characteristics 20, 21 and thus represents an indirect marker of fat quality. ATXN1 was associated with SATHU among men only (P = 1.4 × 10 −8 ), with no association among women (P = 0.36; Supplementary Table 10f) . Examination of related ectopic-fat traits indicated a similar direction of association with VATHU and an opposite direction for SAT and VAT (Supplementary  Table 10f ), consistent with epidemiology findings 7 .
The ratio of visceral to subcutaneous fat volumes (VAT/SAT ratio) represents the propensity to store fat viscerally. UBE2E2 was associated with VAT/SAT ratio (P = 3.1 × 10 −10 ); a nominal association was also identified with VAT (P = 1.4 × 10 −3 ) but not SAT, suggesting that the finding is mostly driven by the higher relative abundance of VAT. The direction of association in both sex strata was consistent (Supplementary Table 10g ). Two known body fat distribution loci, LYPLAL1 and LY86, were also associated with VAT/SAT ratio at genome-wide significance ( Table 1) , consistent with our prior analyses 12, 22 .
Calculation of the false discovery rate (FDR) to account for multiple testing across the 27 meta-analyses showed that all ectopic-fat loci that attained genome-wide significance in each individual genome-wide association study (GWAS) (P < 5 × 10 −8 ) also attained an FDR < 1%.
To examine the association of the seven newly identified ectopicfat loci with BMI and WHR, we performed cross-trait evaluations for each lead SNP in the most recent GIANT meta-GWAS, with sample sizes ~10-20 times greater than that of the current study 14, 15 . Only 2 of 14 SNP-trait (BMI or WHR) associations were significant after Bonferroni correction for multiple testing (P < 0.05/14 SNP-trait tests = 3.6 × 10 −3 ; Supplementary Table 10a-g), highlighting the specificity and uniqueness of the ectopic-fat loci.
To evaluate the relationship between the known 97 BMI-associated and 49 WHR-associated loci 14, 15 and ectopic-fat traits, we examined the association of these loci with fat volume and relative fat volume traits among the combined multiethnic sample of women and men. Because the ectopic fat data may be underpowered for determination of statistically significant results, we hypothesized that the direction of the BMI and WHR findings would be directionally consistent with abdominal ectopic traits, even if the P values were not significant (Supplementary Table 11 ). Directionally consistent SNP-trait associations between SAT and BMI were observed for 87 of 97 loci (P binomial = 8.9 × 10 −17 ). When restricted to the 27 loci that were nominally associated with SAT (P SAT < 0.05), all 27 SNP-SAT associations were directionally consistent with BMI (P binominal = 7.5 × 10 −9 ). SAT is not Cells were expanded to confluence and then collected at intervals after induction of adipogenic differentiation. Data shown are mean values; error bars represent the s.e.m. Statistical significance (*P < 0.05) was assessed using ANOVA and Sidak's correction for multiple comparisons to data at t = 0. (d) Representative images (n = 9 technical replicates) showing Oil Red O staining of progenitors isolated from subcutaneous adipose tissue and exposed to retroviral delivery of constructs expressing a scrambled control shRNA (sh-Scramble), an Atxn1-specific shRNA (sh-Atxn1) or a Ube2e2-specific shRNA (sh-Ube2e2) during ex vivo expansion and induction of adipogenesis (-) control designates progenitors not exposed to adipogenic induction. Scale bar, 1 mm. (e) Quantification of Oil Red O staining as shown in d in differentiated progenitors isolated from SAT and VAT (n = 9 technical replicates). Statistical significance was assessed using ANOVA and Sidak's correction for multiple comparisons relative to controls. Data are representative of three independent experiments. In a,b,e, data are displayed as box-and-whisker plots in which the center line represents the median, the box limits reflect the 25th to75th percentiles, and the whiskers extend to the maximum and minimum values.
an ectopic-fat depot and may represent a metabolic sink for healthier fat storage that is highly correlated with BMI and shares genetic risk factors (as shown by the enriched number of direction-consistent associations), yet it also represents a unique metric of fat distribution with unique genetic influences (as shown with the GSDMB-SAT association). No other traits showed directionally consistent associations with the BMI or WHR (all P > 0.05). These results further underscore how ectopic-fat traits are uniquely disparate traits as compared to BMI and WHR.
Ectopic-fat depots are associated with cardiometabolic risk and cardiovascular events [8] [9] [10] [11] . To gain insight into potential mechanisms linking these conditions, we evaluated the association of the new ectopic-fat loci with traits from large-scale genetics consortia. Of 66 pairs of lead SNP-trait associations examined, three associations (UBE2E2-type 2 diabetes (T2D), EBF1-triglycerides and EBF1-HDL cholesterol) were statistically significant after Bonferroni correction for multiple testing (P < 0.05/66 = 8 × 10 −4 ; Supplementary Table 12) .
To examine whether any of the new variants overlap with known regulatory regions in adipose tissue, we investigated lead SNPs and variants in linkage disequilibrium (LD) with the lead SNPs (r 2 > 0.8) using ENCODE Consortium data implemented in HaploReg 23 and RegulomeDB 24 . Except for ATXN1, all of the loci contained SNPs in LD with the lead SNP that overlapped with known regulatory regions in adipose tissue. For example, the lead UBE2E2 variant (rs7374732), and other SNPs in LD, overlapped with a known enhancer region in adipose-derived stem cells (Supplementary Table 13 ).
The list of candidate loci was further prioritized on the basis of visual examination of regional association plots ( Supplementary  Fig. 1 ) and identification of either a localized association within a gene body at each locus (RREB1, ATXN1 and UBE2E2) or a localized association near the gene body concomitant with the lack of other genes within 1 Mb of the lead SNP (EBF1). By applying these criteria, we selected four genes for additional functional study.
To test the hypothesis that inter-depot differences in gene expression or their dynamic regulation during adipocyte development would identify candidates with a higher likelihood of functional significance, we assessed the expression of four genes (Ebf1, Rreb1, Atxn1 and Ube2e2) in mouse SAT, VAT and PAT depots by qPCR. Ube2e2 had higher expression in the perigonadal VAT of 6-week-old C57BL/6 mice than in the SAT (2.1-fold, P < 0.05, n = 5) or PAT (2.6-fold, P < 0.01, n = 5), but no differences were observed for Ebf1, Rreb1 or Atxn1 (Fig. 1a) . We also assessed differential gene expression of these four genes in mice with diet-induced obesity. We observed a 2.1-fold induction of Atxn1 expression in SAT of diet-induced obese mice relative to lean controls (P < 0.05, n = 6). We did not observe significant differences in expression of Ebf1, Rreb1 or Ube2e2 in response to the obesogenic stimulus (Fig. 1b) .
To explore a potential role for the candidate genes in adipocyte development, we examined their regulation during ex vivo adipogenic differentiation of progenitor-rich stromal-vascular cell fractions isolated from the subcutaneous and visceral depots of C57BL/6 mice. We measured the expression of candidate genes at regular intervals during adipogenic differentiation. In progenitors isolated from both VAT and SAT, we observed significant downregulation of Atxn1, Ube2e2 and Ebf1 during adipogenesis ( Fig. 1c and Supplementary Fig. 5 ). However, in all three instances, the expression returned to near-baseline levels by 96 h after adipogenic induction. In contrast, we observed no significant transcriptional regulation of Rreb1 after adipogenic induction (Supplementary Fig. 5 ).
Both Atxn1 and Ube2e2 showed evidence of dynamic regulation of gene expression during adipogenesis with variable depot-specific expression in the mouse models, providing a rationale for further exploration of their functional significance with a genetic loss-of-function assay. Knockdown of both genes with specific short hairpin RNA (shRNA) retroviral constructs during ex vivo adipogenesis of SAT progenitors impaired the formation of lipid-containing adipocytes relative to vector-control-infected cells, whereas only Ube2e2 knockdown impaired adipogenesis in progenitors isolated from VAT (Fig. 1d,e) .
Our findings provide insight into the genetics of body fat distribution. The scant number of significant associations observed between the ectopic-fat loci and more general measures of adiposity, such as BMI and WHR 14, 15 , demonstrates the specificity of the ectopic-fat associations, highlights the use of precise phenotyping of fat distribution, and suggests that different mechanisms are involved in ectopicfat storage as compared to more general adiposity measures. This specificity was particularly notable for PAT loci, which demonstrated no associations with SAT, VAT, VAT/SAT ratio, BMI or WHR.
In addition, we observed few cross-trait associations for ectopic-fat loci and other cardiometabolic traits, which is noteworthy given the epidemiologic associations between ectopic fat and cardiometabolic risk [1] [2] [3] [4] [5] . One notable exception is UBE2E2, which is a known T2D locus 25, 26 . The lead T2D SNP does not seem to be in LD with the lead SNP from our study (r 2 (rs7374732, rs7612463) < 0.08 across all HapMap2 populations) and therefore probably represents an independent signal. The major allele at rs7374732 is associated with both a lower VAT/SAT ratio and a lower risk of T2D, suggesting that targeting relative fat distribution may have beneficial downstream effects.
Functional studies support physiological roles for UBE2E2 and ATXN1 through regulation of adipocyte differentiation. ATXN1 encodes a chromatin-binding factor involved in the repression of Notch signaling. It has been implicated in neurologic diseases, including spinocerebellar ataxia 1, but there are no reported associations between SNPs in ATXN1 and adiposity-related traits. In contrast, UBE2E2 is a known T2D GWAS locus [25] [26] [27] , although the markers were in low LD with the lead SNP in the present study. UBE2E2 (3p24.2) encodes the ubiquitin-conjugating enzyme E2E2, which is expressed in human pancreas, liver, muscle and adipose tissues. The present GWAS results highlight UBE2E2 in association with the VAT/SAT ratio, a measure of the relative propensity to store fat in the visceral cavity rather than in the subcutaneous compartment. We therefore speculate that SNP-associated modulation of gene expression or of protein function may affect adiposity through an effect on adipocyte differentiation, and relative impairments in adipocyte development may partially explain a default propensity to deposit fat viscerally rather than subcutaneously.
Given the uniqueness of the ectopic-fat traits, the sample size was limited as compared to those in other meta-analyses. Moreover, identification of candidate genes based on proximity to a GWAS signal may miss long-distance interactions between genes and regulatory domains. In contrast, multiethnic analyses, such as those in this study, not only enhance generalizability but also may boost power for certain traits, particularly in contexts of limited allelic heterogeneity. The possibility of false-positive loci is also a consideration, given the absence of external replication. However, all newly identified loci had an FDR < 1%. Such statistical limitations were further mitigated in the case of ATXN1 and UBE2E2 by functional validation of these loci in mouse adipose tissue.
By combining large-scale discovery human genetics with detailed fat phenotyping and experiments in a model organism, we identified seven new loci associated with ectopic-fat traits, of which ATXN1 and UBE2E2 demonstrated a functional effect during adipocyte differentiation. Future studies should further explore the exact mechanism by which Trait assessment. The traits measured in this study can be categorized into three groups: (i) fat volume measurements-subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and pericardial adipose tissue (PAT); (ii) fat attenuation measurements-subcutaneous adipose tissue attenuation (SATHU) and visceral adipose tissue attenuation (VATHU); and (iii) relative fat distribution measurements-visceral-to-subcutaneous adipose tissue volume ratio (VAT/SAT ratio). All volume-based measures were assessed by computed tomography (CT) or magnetic resonance imaging (MRI) according to study-specific protocols; attenuation-based measures were assessed by CT according to study-specific protocols. Please see Supplementary Table 2 and the Supplementary Note for further details.
The following traits were analyzed for each cohort in the overall sample and in women and men separately: volume-based traits (SAT, VAT, VAT adjusted for BMI, PAT, and PAT adjusted for height and weight), attenuation-based traits (SATHU and VATHU), and relative-distribution traits (VAT/SAT ratio and VAT/SAT ratio adjusted for BMI pericardial traits). The rationale for including the ectopic-fat traits, the adjustment models, and the sex-stratified analyses was fourfold. First, ectopic-fat measures are correlated with each other and with general adiposity, and we wished to adjust for these factors as potential confounders or intermediates and to examine the genetic associations independent of the adjustment factor. Please refer to Supplementary Table 7 for pairwise correlations of all traits within the FHS, the largest participating cohort. For example, the correlation between VAT and BMI is 0.71-0.75, and adjusting for BMI when examining VAT provides the relative amount of VAT controlling for the degree of general adiposity. Although the correlations between VAT/SAT ratio and BMI are modest, adjusting for BMI allowed us to examine the propensity to store fat viscerally rather than subcutaneously, independent of general adiposity. Second, adjustment of covariates reduces the residual variance of the trait associated with the given covariate and thus increases power to detect genetic associations. Third, in the adiposity genetics literature, there is evidence of sexually dimorphic loci in which the variance explained is larger in women than in men 28 and association of the loci is markedly stronger in women than in men, and vice versa 14, 22 . Lastly, we adjusted PAT for height and weight to be consistent with our prior work 13 (see Supplementary Table 1 for a guide to nomenclature for traits and adjustment models).
Because of the known differences in body fat distribution by sex, for each cohort we created sex-and ancestry-specific residuals that were adjusted for age, age-squared, smoking status, measures of subpopulation stratification and family structure (if necessary). Family-based studies created an additional set of residuals from all of the participants (both women and men) to account for family structure when analyzing the overall sample. Participants with missing genotype, phenotype or covariate data were excluded from analysis as pre-specified in the analysis plan.
Study-specific protocol. Trait measurements and descriptions from each cohort are available in the Supplementary Note under "Cohort-specific information and protocols."
Genotyping and imputation. We genotyped each cohort as specified in Supplementary Table 4 and performed ancestry-specific imputation up to ~2.6 million SNPs based on the HapMap Project Phase 2 haplotypes (http://hapmap.ncbi.nlm.nih.gov/index.html.en). All newly identified loci were imputed with imputation qualities of >0.8 in each cohort. Imputation qualities by locus and cohort are available in Supplementary Table 8 .
Heritability analysis. Heritability was estimated from the FHS using variance components analysis in SOLAR 16 .
Genetic correlation analysis.
Pairwise genetic correlations among subcutaneous fat (volume and attenuation), visceral fat (volume and attenuation), ratio of visceral-to-subcutaneous fat and BMI were calculated using SOLAR 16 in the FHS among 3,312 participants. We used residuals adjusted for age and sex. Two separate hypotheses were tested: (i) RhoG = 0 is the test for overlapping genetic correlations, and (ii) absolute value (RhoG) = 1 is the test for non-overlapping genetic correlations.
Statistical analysis.
Within each cohort, by ancestry and by sex, we conducted genome-wide linear regression analyses on the 9 trait and model combinations assuming an additive genetic model using allele dosages. All traits approximated a normal distribution, and untransformed traits were used for analysis. To prevent the undue influence of rare variants and/or of poorly imputed SNPs, we included variants with a minor allele count of >10 and imputation quality of >0.4 (for MaCH 29 ) or >0.3 (for IMPUTE 30 ) in each cohort.
For multiethnic analysis, we combined all cohort-specific results using a sample-size-weighted fixed-effects meta-analysis (Stouffer's method), as implemented in METAL 18, 19 , to allow for differences in trait measurement and scaling due to different imaging modalities across cohorts. European and African ancestry cohorts contributed to all ectopic-fat traits; Chinese and Hispanic ancestry cohorts contributed only to pericardial volume traits (Supplementary Table 3 ). All analyses were performed for the overall sample (all), among women only (women) and among men only (men). All analyses were corrected for genomic control at the cohort level. We excluded variants with a minor allele frequency (MAF) < 5% because of the low power to detect associations of such variants. We set a traditional genome-wide significance threshold at P < 5 × 10 −8 , the Bonferroni correction for the number of independent and common variants across the genome (~1 million SNPs).
All P values represent two-sided P values unless otherwise specified. All regional association plots, Manhattan plots, and QQ plots were created using R version 3.1.1 (https://cran.r-project.org/). Linkage disequilibrium plots were created using SNAP 31 and the gap R package (https://www.jstatsoft.org/ article/view/v023i08).
To correct for multiple testing, we calculated FDR across the 27 ectopic-fat GWAS scans using the qvalue R package (http://github.com/jdstorey/qvalue). FDR < 1% was set as the multiple-testing-corrected significance threshold.
For mouse studies, individual cages of mice were randomly assigned in an unblinded fashion to normal chow or a high-fat diet. Each in vivo study was conducted one time, and no mice were excluded from the analyses. In the absence of a priori data regarding the variance of gene expression in the tissues of interest, we applied sample sizes that have, in our experience, been of sufficient size to detect a twofold increase in gene expression. For normally distributed data from more than two groups (Shapiro-Wilk), we conducted an ANOVA test followed by Sidak's correction for multiple testing (Fig. 1a,c,e) . For non-normal data, we used a Kruskal-Wallis test. For comparisons between two normally distributed groups (Fig. 1b, chow versus high  fat) , we used a two-sided t-test, unless the data were non-normal, in which case we used a Mann-Whitney test. Data were expressed as mean and s.e.m. Significance was assigned for two-sided P < 0.05. Data were analyzed and graphed using JMP 10.0 (SAS institute) and Prism 6 (GraphPad).
Sensitivity analyses.
To ensure that the newly identified loci from our multiethnic analysis were robust and not driven by statistical outliers related to ancestry, we compared ancestry-specific meta-analysis results with each other with respect to the minor allele, the minor allele frequency and the direction of the z-score association statistic (Supplementary Table 9 ). Owing to the scaling differences in imaging modalities across each cohort and the use of the sample-size-weighted meta-analysis, heterogeneity statistics cannot be calculated.
The lead SNP for the GSDMB locus associated with SAT in women was not observed in non-European ancestry cohorts and thus was not included in this analysis. For each of the remaining six lead SNPs from the newly identified ectopic-fat loci, z-scores were directionally consistent across ancestry-specific meta-analyses (see Supplementary Fig. 2 for forest plots of each locus and Supplementary Fig. 3 for linkage disequilibrium plots across ancestry). For five of these loci, the minor allele was identical across different ancestries; only the minor allele of rs2842895 (RREB1) differed between the European ancestry and African ancestry cohorts. This observation may explain the slight attenuation in the association of RREB1 and VATadjBMI after combination of European and African ancestry cohorts in the multiethnic meta-analysis (P European-ancestry = 5.8 × 10 −9 to P multiethnic = 1.1 × 10 −8 ), although the multiethnic result remained significant genome-wide.
Analyses of related traits. For each SNP attaining genome-wide significance in association with any ectopic-fat trait, we extracted association results in each strata of analysis (all, women, and men) for related ectopic-fat traits within our study.
To investigate the association of the new ectopic-fat loci with measures of generalized adiposity (BMI) and central obesity (WHR)-two traits that are strongly correlated with, but distinct from, ectopic fat-we evaluated the lead genome-wide significant SNPs in publicly available data sets from the most recent GIANT meta-analyses of BMI and WHR 14, 15 .
To investigate associations of new loci with cardiometabolic traits that are epidemiologically associated with ectopic fat, we performed cross-trait evaluations for the lead SNPs in only the publicly available data sets from MAGIC (Meta-Analyses of Glucose and Insulin Consortium for fasting glucose and insulin 32 ), GLGC (Global Lipids Genetics Consortium for high-density lipoprotein cholesterol, triglycerides, and total cholesterol 33 ), the Coronary ARtery DIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) plus the Coronary Artery Disease (C4D) Genetics for coronary artery disease and myocardial infarction 34, 35 (CARDIoGRAM + CAD) consortium, the International Consortium for Blood Pressure for systolic and diastolic blood pressure 36 (ICBP), and the DIAbetes Genetics Replication and Meta-analysis 25 (DIAGRAM) consortium.
Analysis of general adiposity and central adiposity loci. To evaluate the relationship between the known 97 BMI and 49 WHR loci 14, 15 with ectopic-fat traits, we examined the association for these loci with fat volume and relative fat volume traits among the combined multiethnic sample of women and men. As the ectopic-fat data may have been underpowered to determine statistically significant results, we hypothesized that the direction of the BMI and WHR findings would be directionally consistent with the ectopic-fat traits, even if the P values were not significant. Binominal tests were used to test the significance of direction-consistent associations (one-sided P values). If the binominal test across the BMI or WHR loci was significant, we then performed a second one-sided binominal test evaluating the consistency of associations restricting to SNPs with nominally significant associations (P < 0.05).
Functional profiling, bioinformatics and annotation. To further characterize novel genome-wide significant loci, we queried the following bioinformatics databases for the lead ectopic-fat loci: GWAS Catalog (https://www.ebi. ac.uk/gwas/; accessed 15 October 2015) to investigate other traits associated with newly identified loci, and HaploReg 23 and RegulomeDB 24 to identify regulatory elements overlapping the loci for the index SNP and SNPs in LD with the index SNP (r 2 > 0.8; Supplementary Table 13) . To contextualize the newly identified ectopic loci and the surrounding genes, we used SNIPPER (https://github.com/welchr/Snipper.git) to search for biologically relevant mechanisms (Supplementary Table 14) .
Variance explained. The variance explained for each of the loci was approximated using the following formula: R 2 = β 2 var(SNP)/var(ectopic-fat trait), where β 2 is the estimated effect of the SNP on the ectopic-fat trait, and var(SNP) = 2 × MAF SNP × (1 -MAF SNP ). Because sample-size-weighted fixed-effect meta-analysis does not estimate effect sizes, the β coefficient for the association between the SNP and ectopic-fat trait and the variance of the ectopic-fat trait were obtained from cohort-level analysis for each contributing study. The mean of the variance explained per locus across all contributing cohorts ranged from 0.1% to 4.4% (Supplementary Table 15) .
Power calculations. Power for discovery in the ectopic-fat genome-wide scan was calculated using GWAPower 37 using the range of sample sizes in this study (5, ,332 participants) and setting α = 5 × 10 −8 . For the smallest sample size analyzed (n = 5,842) we had ≥80% power to detect loci explaining at least 0.64% of the trait variance. For the largest sample size analyzed (n = 18,332), we had ≥80% power to detect loci explaining at least 0.20% of the trait variance. For example, our newly identified loci explained from 0.15% to 4.4% of the trait variance for ectopic fat as seen in Supplementary Table 15 .
To address the power to detect associations for the lookup analyses, we used GWAPower 37 with the maximum sample sizes from each of the quantitative-trait data sets (52,000-94,000 participants), a modest range of variance explained (0.01-0.05% based on the variance explained for each locus (0.1-4.4%), and the age-adjusted correlations between ectopic fat and the cardiometabolic trait of interest (R 2 = 0.02-0.46)) and a Bonferroni-corrected α = 7.4 × 10 −4 (~0.05/66 pairs of SNP-trait associations). For the smallest data set (fasting insulin, n ~52,000), we had 80% power to detect loci explaining at least 0.030% of the variance in fasting insulin. For the largest data set (high-density lipoprotein (HDL)-C and total cholesterol, n ~94,000), we had 80% power to detect loci explaining 0.018% of the variance in HDL-C or total cholesterol. These calculations indicate that we largely had adequate power for a large portion of the SNP-trait associations.
Expression quantitative trait locus (eQTL) analysis. Using a curated collection of six eQTL data sets in adipose-related tissues, we examined index SNPs at newly identified ectopic-fat loci for association with transcript expression. Data sets were collected through publications, publicly available sources, or private collaboration. The eQTL data sets met criteria for statistical thresholds for SNP-gene transcript associations as described in the original papers and were limited to index SNPs and SNPs in LD with the index SNP (r 2 > 0.8) across all ancestries available in the 1,000 Genomes Project pilot (SNAP 31 ). A general overview of the larger collection of more than 50 eQTL studies from which the adipose-related data sets (omental, visceral and subcutaneous adipose [38] [39] [40] [41] [42] ) were derived has been published 43 . Additional eQTL data were integrated from online sources including ScanDB, the Broad Institute GTEx portal, and the Pritchard Lab (http://eqtl.uchicago.edu). Results for GTEx analysis V4 for subcutaneous adipose tissue were downloaded from the GTEx portal and then additionally filtered as described below (http://www.gtexportal.org) 41 . Splicing QTL (sQTL) results generated with sQTLseeker with FDR P ≤ 0.05 were retained. For all gene-level eQTLs, if at least one SNP passed the tissue-specific empirical threshold in GTEx, then the best SNP for that eQTL was always retained. All gene-level eQTL SNPs with P < 1.67 × 10 −11 were also retained, reflecting a global threshold correction of P = 0.05/(30,000 genes × 1,000,000 tests).
cis-eQTL analysis showed that SNPs at ENSA (a locus identified in association with PAT) were correlated with multiple transcripts (MRPS21, CTSK and LASS2; P < 10 −4 ) in subcutaneous and omental adipose tissue (Supplementary Table 16 ), suggesting that these may be the relevant transcripts at this locus rather than ENSA, the closest gene to the lead association signal. However, the ENSA locus was not selected for functional validation, as there were too many genes in the region to practically follow up. No other eQTLs were identified.
Selection of loci for characterization in model organisms. For functional follow-up and characterization of ectopic-fat loci, we selected four genetrait associations based on visual examination of regional association plots (Supplementary Fig. 1 ) for a localized association within a gene body at each locus (RREB1, ATXN1 and UBE2E2) or localized association near the gene body and the lack of other genes within 1 Mb of the lead SNP (EBF1) to increase the probability of experimentally testing the likely causal gene in mouse models.
Mouse studies. Experiments were approved by and in compliance with the ethical regulations of the Harvard Medical Area Standing Committee on Animals. C57BL/6 mice were purchased from Charles River and housed at 22 ± 2 °C with a 12-h light (0700-1900 h)/12-h dark (1900-0700 h) cycle and ad libitum access to food and water. Adipose tissue progenitors were isolated from mice 4-6 weeks old. For all other mouse experiments, 8-week-old mice were used. With the exception of the data shown in Supplementary Figure 6 , experiments were conducted in male mice. Diet-induced obesity was modeled with high-fat (D12492) and control normal chow (D12450J) matched for sucrose content (Research Diets, Inc.). Adipose tissues were excised, placed in Trizol (Life Technologies), and homogenized, and then RNA was extracted according to the manufacturer's protocol. cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). qPCR was performed using iTaq Universal SYBR Green Supermix (Bio-Rad) on an iCycler (Bio-Rad) instrument. See Supplementary Table 17 for primer sequences used in these analyses. Gene expression was normalized to the transcript encoding the 18S rRNA. The ∆∆C T method was used to calculate fold change in transcript levels.
Comparison of baseline adipose-specific expression of Atxn1. Given that the SNP-ectopic fat association for ATXN1 was confined to men, we assessed sex-specific effects of Atxn1 expression in mice. There was no detectable sex effect on the baseline, adipose-specific expression of Atxn1 (Supplementary Fig. 6 ).
Adipogenesis assay. Adipose tissue from C57BL/6 mice was minced and digested with collagenase D (Roche) in a shaking water bath (37 °C, 225 r.p.m., 40 min). The digest was centrifuged at 400g for 10 min. Pelleted stromal vascular cells were filtered (40 µm) and then washed with PBS and subjected to additional negative selection (CD31 − lineage − ) adapted from previous methods 44 using antibody-coated microbeads (Miltenyi Biotec). Cells were cultured to confluence in collagen-coated plates and stimulated with dexamethasone, insulin, and 3-isobutyl-1-methylxanthine to induce adipogenic differentiation. For genetic loss-of-function assays, a validated shRNA sequence (Broad, Ube2e2, TRCN0000040962; Atxn1, TRCN0000240655) or a scramble sequence was subcloned into a retroviral vector (pMKO.1). Gene expression knockdown efficiency was confirmed by qPCR in 3T3L1 cells; in each instance reproducibly achieved a minimum of 60% reduction of transcriptional activity. Differentiation into mature lipid-containing adipocytes was determined by Oil Red O (ORO) staining and quantified by measurement of alcohol-extracted ORO dye at an optical density of 520 nm (OD 520 ).
Cohort-specific acknowledgments and funding. Please see the Supplementary Note for acknowledgments and funding statements for all of the participating cohorts.
Data availability statement. Summary statistics for all meta-analyses will be made available at https://www.nhlbi.nih.gov/research/intramural/ researchers/ckdgen.
